Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain.
D000679:Amygdala / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D005260:Female; D005333:Fetus; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D008694:Methamphetamine / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010622:Phencyclidine / Q000494:pharmacology; D011149:Pons / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D013788:Thalamus / Q000378:metabolism; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D008694:Methamphetamine; D010622:Phencyclidine; D007099:Imipramine; D002746:Chlorpromazine; D009638:Norepinephrine